Rakuten Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Sell
37,692
-2,551
-6% -$66.7K 0.21% 66
2026
Q1
$1.13M Sell
40,243
-7,423
-16% -$198K 0.47% 46
2025
Q4
$1.19M Sell
47,666
-438
-0.9% -$11K 0.39% 45
2025
Q3
$1.23M Buy
48,104
+21,058
+78% +$520K 0.45% 48
2025
Q2
$656K Sell
27,046
-865
-3% -$20.2K 0.26% 57
2025
Q1
$707K Sell
27,911
-1,513
-5% -$39.6K 0.36% 43
2024
Q4
$781K Buy
29,424
+2,734
+10% +$74.2K 0.31% 40
2024
Q3
$772K Sell
26,690
-4,301
-14% -$125K 0.34% 40
2024
Q2
$867K Sell
30,991
-1,319
-4% -$36.3K 0.37% 39
2024
Q1
$897K Sell
32,310
-15,276
-32% -$424K 0.39% 35
2023
Q4
$1.37M Buy
+47,586
New +$1.44M 1.08% 18

Other funds holding PFE

Rakuten Securities's PFE Position: Q2 2026 in Review

Rakuten Securities reduced its Pfizer (PFE) stake by 6.3% in Q2 2026, selling an estimated $66.7K and leaving 37,692 shares worth $908K. The position accounts for 0.21% of the portfolio, ranked #66.

Rakuten Securities first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.37M in Q4 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rakuten Securities held 37,692 shares of Pfizer worth $908K as of Q2 2026.
  • Rakuten Securities sold 2,551 Pfizer shares in Q2 2026, an estimated $66.7K.
  • Pfizer made up 0.21% of Rakuten Securities's portfolio in Q2 2026, its #66 holding.
  • Rakuten Securities first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Pfizer position peaked at $1.37M in Q4 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.